Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content
HomeCompareSaxenda vs Rybelsus

Medication comparison

Saxenda vs Rybelsus

Saxenda and Rybelsus are both prescription medications (GLP-1 receptor agonist (daily injection) vs GLP-1 receptor agonist (oral tablet)) used for Chronic weight management (adults + adolescents 12+) and Type 2 diabetes. The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.

Find a provider for Saxenda or Rybelsus

Affiliate disclosure: we earn commission on signups. Editorial ranking stays independent.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Top 3 providers prescribing Saxenda or Rybelsus

Affiliate links — we earn commission on conversions; editorial ranking is independent.

Overview

PropertySaxendaRybelsus
Generic nameliraglutidesemaglutide (oral)
Drug classGLP-1 receptor agonist (daily injection)GLP-1 receptor agonist (oral tablet)
ManufacturerNovo NordiskNovo Nordisk
Brand namesSaxendaRybelsus

Approved uses

PropertySaxendaRybelsus
Approved indicationsChronic weight management (adults + adolescents 12+)Type 2 diabetes

Dosing

PropertySaxendaRybelsus
Typical dosing

Side effects & warnings

PropertySaxendaRybelsus
Top side effects
Contraindications
Boxed warningNoNo

Special populations

PropertySaxendaRybelsus
Pregnancy

Storage

PropertySaxendaRybelsus
Storage

Cost

PropertySaxendaRybelsus
Avg monthly cost$1349.00$1029.00

Frequently asked

What is the difference between Saxenda and Rybelsus?

Saxenda is liraglutide (GLP-1 receptor agonist (daily injection)) and Rybelsus is semaglutide (oral) (GLP-1 receptor agonist (oral tablet)). They have different active ingredients and slightly different side-effect profiles.

Is Saxenda or Rybelsus more effective for weight loss?

See each drug's clinical-trials section for the registrational outcome data (SURMOUNT for tirzepatide; STEP for semaglutide; SCALE for liraglutide). Average weight loss varies by trial duration, dose ceiling, and adherence.

Can I switch between Saxenda and Rybelsus?

Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.

Other GLP-1 head-to-head comparisons

More medication context

Tools and guides that pair with this comparison.

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.